Archives: Technologies

Transforming Oral Delivery of Peptide Drugs Innovative Salt-Based Platform Developed at the Hebrew University of Jerusalem A novel technology developed at the Hebrew University offers a new and efficient way to deliver peptide drugs orally—eliminating the need for injections in many cases. This platform is based on a re-engineered version of the widely used absorption […]...

Application: Current topical delivery methods for lipophilic molecules like cannabinoids often fail to deliver effective concentrations beyond the outer skin layer. Existing solutions rely on high levels of solvents, raising safety, stability, and efficacy concerns. There is a strong medical and cosmetic need for effective, solvent-free delivery systems capable of penetrating the skin barrier and […]...

About Novel antifungal  small molecule PA-X1, synthesize in the laboratory and identical to a compound  produced by Pseudozyma aphidis shows potent activity against major crop pathogens, offering a new eco-friendly solution for agricultural plant protection. Background Fungal plant pathogens cause significant crop losses worldwide, estimated at over $200 billion annually. Current solutions face challenges including […]...

About Novel magnesium-based technology that increases cheese protein yield by 33%, prevents bacterial contamination, and enhances product safety while adding nutritional benefits. Researchers: Prof. Moshe Shemesh; Department of Food Quality and Safety, Agricultural Research Organization Prof. Ram Reifen, Department of Food Science and Nutrition, The Hebrew University of Jerusalem Background The dairy industry faces significant […]...

Abstract Advanced electrochemical biosensor array utilizing highly selective peptide recognition elements for rapid bacterial detection. The technology combines optimized peptide bacterial binders combined with surface chemistry using sophisticated electrochemical detection methods, enabling sensitive and selective pathogen identification within minutes. Background The global bacterial detection market is expected to reach $19.5 billion by 2027, growing at […]...

Gilad Marcus, Applied Physics Institute, Hebrew University Salman Noach, Jerusalem College of Technology, Avital Bechar, Volcani Institute, Ministry of Agriculture and Rural Development. Ran Lati, Volcani Institute, Ministry of Agriculture and Rural Development. Abstract An autonomous lightweight weeding system that identifies and targets weeds for shooting a suitable irradiation beam for weed elimination. Background What […]...

Abstract A novel approach demonstrating that antiviral treatment reduces fungal virulence, providing potential therapeutic strategy for invasive fungal infections. Background The global antifungal therapeutics market is projected to reach $25 billion by 2030, with invasive fungal infections representing a significant segment. Invasive fungal infections pose a significant global health threat with ~50% mortality rate. Aspergillus […]...

Abstract Custom-made strategy for the directed evolution of beneficial enzymes. A high-throughout platform for identifying superior enzyme variants, demonstrated by engineering herbicide-detoxifying enzyme. Background The global industrial enzymes market, valued at $6.4 billion in 2022, is projected to reach $8.7 billion by 20271. Agricultural applications, particularly herbicide management, represent a critical segment. Current enzyme discovery […]...

Application: Our innovation: Our revolutionary approach reacts rock or building waste with oxalic acid at room temperature and pressure to create oxalate minerals. We achieve high conversion in a matter of days to weeks. The process is also twice as efficient because oxalate contains 2 carbon atoms. Advantages: Opportunity:                 We are seeking collaboration with energy […]...

Application:           The synthetic peptide therapeutics market is experiencing remarkable growth, projected to reach $49.5B by 2027, driven by increasing applications in cancer treatment, metabolic disorders, and rare diseases. Cancer therapeutics alone account for over 20% of the market, with neuropeptides emerging as a rapidly growing segment due to rising neurological and autoimmune disorders. Despite this […]...